Literature DB >> 23663061

Sodium thiosulfate in the treatment of non-uremic calciphylaxis.

Matthew S Ning1, Kathryn M Dahir, Emily H Castellanos, Laura Y McGirt.   

Abstract

Calciphylaxis is a metastatic calcification-induced vasculopathy that results in the occlusion of small blood vessels. Although calciphylaxis is normally associated with end-stage renal disease, calciphylaxis from non-uremic origin occurs as well. While the number of reports continues to increase, a standard treatment for non-uremic calciphylaxis has yet to be established. Sodium thiosulfate (STS), which has been proven to be effective in the treatment of uremic calciphylaxis, shows promise; however, reports of its use in non-uremic cases are limited. We describe a case of non-uremic calciphylaxis in a patient with normal renal and parathyroid function who had complete resolution of disease after treatment with STS, and we review similar cases in the published work. Based on the successful outcomes detailed in this case series, STS appears to be an effective therapy for non-uremic calciphylaxis.
© 2013 Japanese Dermatological Association.

Entities:  

Keywords:  non-uremic calciphylaxis; sodium thiosulfate; uremic calciphylaxis; vasculopathy

Mesh:

Substances:

Year:  2013        PMID: 23663061     DOI: 10.1111/1346-8138.12139

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  8 in total

1.  Non-uraemic calciphylaxis successfully treated with pamidronate infusion.

Authors:  David H Truong; Marcus M Riedhammer; Kathya Zinszer
Journal:  Int Wound J       Date:  2018-11-04       Impact factor: 3.315

Review 2.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

3.  Benefits of intralesional injections of sodium thiosulfate in the treatment of calciphylaxis.

Authors:  Kirsi Isoherranen; Laura Bouchard; Nicolas Kluger
Journal:  Int Wound J       Date:  2017-03-21       Impact factor: 3.315

4.  Mutant Enpp1asj mice as a model for generalized arterial calcification of infancy.

Authors:  Qiaoli Li; Haitao Guo; David W Chou; Annerose Berndt; John P Sundberg; Jouni Uitto
Journal:  Dis Model Mech       Date:  2013-06-20       Impact factor: 5.758

5.  Calciphylaxis Presenting with Various Symptoms: A Case Report.

Authors:  Shinpei Miura; Kazuhiro Takahashi; Toshihide Akasaka
Journal:  Case Rep Dermatol       Date:  2017-02-08

6.  Nonuremic calciphylaxis manifesting with diffuse dermal angiomatosis.

Authors:  Francine T Castillo; Ritesh Agnihothri; Lindy P Fox; Jeffrey P North; Anna K Haemel
Journal:  JAAD Case Rep       Date:  2022-04-04

Review 7.  POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.

Authors:  Nobuyuki Araki; Sonoko Misawa; Kazumoto Shibuya; Satoshi Ota; Takashi Oide; Asuka Kawano; Minako Beppu; Yukio Nakatani; Satoshi Kuwabara
Journal:  Orphanet J Rare Dis       Date:  2016-04-12       Impact factor: 4.123

8.  Topical cannabis-based medicines - A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial.

Authors:  Vincent Maida; Runjie B Shi; Francesco G T Fazzari; Lydia Zomparelli
Journal:  Int Wound J       Date:  2020-09-02       Impact factor: 3.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.